Related Experiment Video
Updated: Jun 18, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis
Lorna R Fiedler1, Beata Wojciak-Stothard
1Department of Clinical Pharmacology and Therapeutics, BHF Laboratories, 5 University Street, Rayne Institute, University College London, London WC1E 6JJ, UK.
Abstract:
ADMA (asymmetric dimethylarginine) is a cardiovascular risk factor and an endogenous inhibitor of NOS (nitric oxide synthase). ADMA is metabolized by DDAHs (dimethylarginine dimethylaminohydrolases). ADMA levels are increased in cardiovascular disorders associated with abnormal angiogenesis but the mechanisms are poorly understood. Recent studies show that altering ADMA metabolism in vivo and in vitro modulates the activity of Rho GTPases, key regulators of actin dynamics, endothelial cell motility and angiogenesis. In the present review, we consider this and other NO-dependent and -independent molecular mechanisms by which the DDAH/ADMA pathway regulates angiogenesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Intracellular Signaling Affects Focal Adhesions
Some...

